Showing results (41-50 of 2,576) with videos related to

Sort By:
Pageof 258
Molecular Oncology|May 7, 2021
Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cellsAleksandra Glogowska, Thatchawan Thanasupawat, Jason Beiko, et al.
Molecular Oncology|May 13, 2021
A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedinDavid S Moura, Maria Peña-Chilet, Juan Antonio Cordero Varela, et al.
Molecular Oncology|May 1, 2021
The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancerRahul Sreekumar, Hajir Al-Saihati, Muhammad Emaduddin, et al.
Molecular Oncology|May 1, 2021
An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancerMohammad Sultan, Jacob T Nearing, Justin M Brown, et al.
Molecular Oncology|May 1, 2021
Protease-activated receptor 1 drives and maintains ductal cell fates in the premalignant pancreas and ductal adenocarcinomaCansu Tekin, Brendon P Scicluna, Sophie C Lodestijn, et al.
Molecular Oncology|May 6, 2021
Tspan5 promotes epithelial-mesenchymal transition and tumour metastasis of hepatocellular carcinoma by activating Notch signallingQian Xie, Huiling Guo, Peirong He, et al.
Molecular Oncology|May 6, 2021
Playing cancer at its own game: activating mitogenic signaling as a paradoxical interventionMatheus Henrique Dias, René Bernards
Molecular Oncology|May 21, 2021
Upregulated functional gene expression programmes in tumour pericytes mark progression in patients with low-grade gliomaClara Oudenaarden, Jonas Sjölund, Kristian Pietras
Molecular Oncology|May 21, 2021
Multiplexed digital spatial profiling of invasive breast tumors from Black and White womenAngela R Omilian, Haiyang Sheng, Chi-Chen Hong, et al.
Molecular Oncology|May 2, 2021
Monitoring levels of circulating cell-free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatmentBrice Pastor, Thierry André, Julie Henriques, et al.
Pageof 258